2021
DOI: 10.1186/s12890-021-01796-w
|View full text |Cite
|
Sign up to set email alerts
|

Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment

Abstract: Background In recent years, immunotherapies and targeted therapies contribute to population-level improvement in NSCLC cancer-specific survival, however, the two novel therapeutic options have mainly benefit patients containing mutated driven genes. Thus, to explore other potential genes related with immunity or targeted therapies may provide novel options to improve survival of lung cancer patients without mutated driven genes. CTSF is unique in human cysteine proteinases. Presently, CTSF has … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 73 publications
0
18
0
Order By: Relevance
“…CTSF was a member of the cysteine cathepsin protease family, which was among the most intensively studied protease families in cancer research 108 . Numerous studies have reported abnormal expression of cathepsin family members in a variety of cancers 109 , and their regulatory roles in cancer have been detailed through extensive mouse model studies 110 . RSPO3, recognized as an oncogenic protein, was implicated in cancer progression in multiple body systems and influenced cancer clinical features 111 .…”
Section: Resultsmentioning
confidence: 99%
“…CTSF was a member of the cysteine cathepsin protease family, which was among the most intensively studied protease families in cancer research 108 . Numerous studies have reported abnormal expression of cathepsin family members in a variety of cancers 109 , and their regulatory roles in cancer have been detailed through extensive mouse model studies 110 . RSPO3, recognized as an oncogenic protein, was implicated in cancer progression in multiple body systems and influenced cancer clinical features 111 .…”
Section: Resultsmentioning
confidence: 99%
“…According to a study by Wei S and colleagues, elevated expression of Cathepsin F in non-small cell lung cancer brain metastasis tissues is correlated with poor progression-free survival and is an independent prognostic factor [56]. Additionally, compared to normal tissues, Cathepsin F is downregulated in non-small cell lung cancer samples, and high expression of Cathepsin F is associated with a favorable prognosis in non-small cell lung cancer [57]. Our data indicate that, in univariable MR analysis, Cathepsin F is a protective factor for the 28-day mortality rate of sepsis.…”
Section: Discussionmentioning
confidence: 99%
“…In research done by Song and colleagues, the expression of CTSF in non-small cell lung cancer was evaluated and downregulated levels of CTST were observed in NSCLC samples despite normal tissues and good prognosis of NSCLC being correlated with high expression of CTSF. Besides using GeneMANIA, the gene-gene interaction network was established for CTSF and showed that CTSF had a similar function as CTSW genes [34]. A study on endometrial cancer reported that the CTSW gene had a positive correlation with tumor in ltration levels of B cells, CD8 + T cells, CD4 + T cells, macrophages, and dendritic cells [33].…”
Section: Discussionmentioning
confidence: 99%